A New AI Tool Personalises Antidepressant Treatment, Improving Outcomes and Prescribing Decisions for Depression
Recent clinical trial results provide promising insights: patients whose medications were selected through this AI system demonstrated lower rates of treatment discontinuation and showed more substantial improvements in their depressive symptoms compared to those receiving standard care.
How the PETRUSHKA AI Tool Works
Administratively simple, the tool combines clinical information, demographic data, and patient preferences—including potential side effects—to create personalized treatment recommendations. The evaluation process is quick, taking only three minutes, and has been tested in randomized clinical trials spanning the UK, Brazil, and Canada, involving over 500 adults with major depressive disorder since its launch in 2024.
Clinical Trial Results and Impact
The clinical trials underscored the efficacy of the PETRUSHKA tool. Participants who utilized the AI-guided antidepressant selection were 40% less likely to discontinue their medication within the first eight weeks of treatment compared to those receiving traditional care. Moreover, fewer individuals stopped treatment due to adverse effects, and by 24 weeks, participants in the PETRUSHKA cohort reported more significant improvements in both depressive and anxiety symptoms.
What sets PETRUSHKA apart is its co-production with people who have experienced depression. This collaborative approach ensures the tool is genuinely applicable in everyday clinical settings, empowering both clinicians and patients to make informed decisions during consultations.
NIHR Research Professor Andrea Cipriani, a key figure in the study and a Professor of Psychiatry at the University of Oxford, articulated a crucial point: “Mental health is lagging behind other fields of medicine, and for too long, antidepressant treatment has relied on trial and error.”
Further emphasizing the significance of this research, Mike Lewis, NIHR Scientific Director for Innovation, remarked: “This study shows the real power of combining digital technology and personalized treatment.” The integration of data-driven insights and innovative digital tools marks a pivotal step towards delivering more precise, effective care for individuals struggling with mental health issues.
